UMOD and chronic kidney disease: The significance of these findings stems from the fact that the lower levels of both lipid parameters (HDL and Apo A-I) in the CKD group suggest a diminished atheroprotective capacity, which, together with the lower uromodulin levels, places these patients at a higher cardiovascular risk.